Mortality rate in treated cases * 0-2% in treated cases among immunocompetent patients * 29% in immunocompromised patients * 40% in the subgroup of patients with AIDS * 68% in patients presenting as acute respiratory distress syndrome (ARDS)
Blastomycosis
Chromoblastomycosis
Actinomycosis
Basidiobolomycosis
Botryomycosis
Conidiobolomycosis
Talaromycosis
Dermatomycosis